Sign In
Buy RVPH
$0.695
+0.0350 (+5.30%)
At Close: Jun 23, 2026
Reviva Pharmaceuticals Holdings, Inc. Reports Second Quarter 2021 Financial Results and Recent Business Highlights
08:15am, Monday, 16'th Aug 2021
-Closed Underwritten Public Offering of Common Stock and Warrants Resulting in Gross Proceeds of $34.5 Million
Reviva Pharma Stock Is Trading Higher After Maxim Initiated With Buy, Target Price Of $10
01:14pm, Monday, 26'th Jul 2021
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) is trading higher with around 60k in session volume. Maxim initiated coverage of Reviva with a Buy rating and $10 price target, equivalent to an u
Reviva Added to Russell Microcap® Index
07:00am, Monday, 28'th Jun 2021
CUPERTINO, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (along with its subsidiaries, “Reviva” or the “Company”), a clinical-stage pharmaceuti
5 Stock Gainers For May 27: VTNR, GOED, RZLT, AMC, RVPH
10:53pm, Thursday, 27'th May 2021
Here is an overview of 5 of the top stock gainers for May 21 and why the stock prices moved. The post 5 Stock Gainers For May 27: VTNR, GOED, RZLT, AMC, RVPH appeared first on Pulse 2.0.
RVPH Stock Price: Over 11% Decrease Pre-Market Explanation
07:31am, Thursday, 27'th May 2021
The stock price of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) decreased by over 11% pre-market. This is why it happened.
Reviva Announces Pricing of Upsized $30 Million Underwritten Public Offering
08:43pm, Wednesday, 26'th May 2021
CUPERTINO, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapi
RVPH Stock: Why Reviva Pharmaceuticals Is Skyrocketing 90% on Monday
03:29pm, Monday, 26'th Apr 2021
Today, investors in RVPH stock saw some pretty massive gains, as the company announced impressive results for its schizophrenia drug. The post RVPH Stock: Why Reviva Pharmaceuticals Is Skyrocketing 90
Why Voyager Therapeutics, uniQure, Axsome, Reviva Pharma and Crispr Are Moving Today
02:18pm, Monday, 26'th Apr 2021
Voyager Therapeutics, Inc. (NASDAQ: VYGR), uniQure N.V. (NASDAQ: QURE), Axsome Therapeutics, Inc. (NASDAQ: AXSM), Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and CRISPR Therapeutics AG (NASDAQ
Here's why Reviva Pharmaceuticals soared more than 100% on Monday
01:29pm, Monday, 26'th Apr 2021
Shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) more than doubled in value Monday after the clinical-stage biopharmaceutical company reported encouraging phase 2 clinical trial results
Reviva's stock jumps after experimental schizophrenia drug meets endpoint in Phase 2 clinical trial
12:33pm, Monday, 26'th Apr 2021
Shares of Reviva Pharmaceuticals Holdings Inc. soared 76.6% in trading on Monday after the company said its experimental treatment for schizophrenia met the primary endpoint in a mid-stage clinical tr
Reviva Pharma Stock Trading Higher On Detailed Positive Schizophrenia Study Results
09:21am, Monday, 26'th Apr 2021
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) has announced the full details of its Phase 2 trial evaluating its lead drug candidate, RP5063 (brilaroxazine), for Acute Schizophrenia. Brilaroxa
RVPH Stock: Over 10% Increase Pre-Market Explanation
07:15am, Monday, 26'th Apr 2021
The stock price of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) has increased by over 10% pre-market. This is why it happened.
Reviva Announces Full Details of Positive Phase 2 Clinical Trial Results for Acute Schizophrenia
06:00am, Monday, 26'th Apr 2021
CUPERTINO, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (along with its subsidiaries, “Reviva” or the “Company”), a clinical-stage pharmaceut
